Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with disease modifying therapies

被引：0
|
作者：
Barone, S. [1 ]
Palmieri, C. [2 ]
Gallelli, L. [3 ]
Rania, V. [3 ]
Bruno, P. A. [1 ]
Pasquale, M. [1 ]
Pascarella, A. [1 ]
Manzo, L. [1 ]
De Sarro, G. [3 ]
Gambardella, A. [1 ]
Valentino, P. [1 ]
机构：
[1] Magna Graecia Univ Catanzaro, Inst Neurol, Dept Med & Surg Sci, Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Clin Biochem & Cell Biol, Biochem Lab, Dept Expt & Clin Med, Catanzaro, Italy
[3] Magna Graecia Univ Catanzaro, Clin Pharmacol Unit, Dept Hlth Sci, Sch Med, Catanzaro, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1091
引用
收藏
页码：866 / 866
页数：1
相关论文
共 50 条
  • [41] Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
    Achiron, Anat
    Mandel, Mathilda
    Dreyer-Alster, Sapir
    Harari, Gil
    Magalashvili, David
    Sonis, Polina
    Dolev, Mark
    Menascu, Shay
    Flechter, Shlomo
    Falb, Rina
    Gurevich, Michael
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [42] Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis
    Ciampi, Ethel
    Uribe-San-Martin, Reinaldo
    Soler, Bernardita
    Garcia, Lorena
    Guzman, Jorge
    Pelayo, Carolina
    Jurgensen, Lukas
    Guzman, Ignacio
    Vera, Francisco
    Galleguillos, Lorna
    Carcamo, Claudia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 59
  • [43] Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
    Bitzenhofer, Michaela
    Suter-Riniker, Franziska
    Moor, Matthias B.
    Sidler, Daniel
    Horn, Michael P.
    Gschwend, Anna
    Staehelin, Cornelia
    Rauch, Andri
    Helbling, Arthur
    Joerg, Lukas
    PLOS ONE, 2022, 17 (06):
  • [44] Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
    Centonze, Diego
    Rocca, Maria A.
    Gasperini, Claudio
    Kappos, Ludwig
    Hartung, Hans-Peter
    Magyari, Melinda
    Oreja-Guevara, Celia
    Trojano, Maria
    Wiendl, Heinz
    Filippi, Massimo
    JOURNAL OF NEUROLOGY, 2021, 268 (11) : 3961 - 3968
  • [45] Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
    Diego Centonze
    Maria A. Rocca
    Claudio Gasperini
    Ludwig Kappos
    Hans-Peter Hartung
    Melinda Magyari
    Celia Oreja-Guevara
    Maria Trojano
    Heinz Wiendl
    Massimo Filippi
    Journal of Neurology, 2021, 268 : 3961 - 3968
  • [46] Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience
    Czarnowska, Agata
    Brola, Waldemar
    Zajkowska, Olga
    Rusek, Stanislaw
    Adamczyk-Sowa, Monika
    Kubicka-Baczyk, Katarzyna
    Kalinowska-Lyszczarz, Alicja
    Kania, Karolina
    Slowik, Agnieszka
    Wnuk, Marcin
    Marona, Monika
    Podlecka-Pietowska, Aleksandra
    Nojszewska, Monika
    Zakrzewska-Pniewska, Beata
    Jasinska, Elzbieta
    Goluch, Katarzyna
    Lech, Beata
    Noga, Magdalena
    Perenc, Adam
    Popiel, Malgorzata
    Lasek-Bal, Anetta
    Puz, Przemyslaw
    Maciejowska, Katarzyna
    Kucharska-Lipowska, Marta
    Lipowski, Michal
    Kapica-Topczewska, Katarzyna
    Chorazy, Monika
    Tarasiuk, Joanna
    Kochanowicz, Jan
    Kulikowska, Joanna
    Wawrzyniak, Slawomir
    Niezgodzinska-Maciejek, Anna
    Pokryszko-Dragan, Anna
    Gruszka, Ewa
    Budrewicz, Slawomir
    Bialek, Marta
    Kurkowska-Jastrzebska, Iwona
    Kurowska, Katarzyna
    Stepien, Adam
    Wlodek, Agata
    Ptasznik, Violetta
    Pawelczyk, Malgorzata
    Sobolewski, Piotr
    Lejmel, Henryka
    Strzalinska, Katarzyna
    Maciejowski, Maciej
    Tutaj, Andrzej
    Zwiernik, Jacek
    Litwin, Anna
    Lewanczyk, Bozena
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2021, 55 (02) : 212 - 222
  • [47] T cell profiling following SARS-CoV-2 mRNA vaccination in multiple sclerosis patients treated with DMT's
    Solchenberger, Hannah
    Odendahl, Marcus
    Schriefer, Dirk
    Ziemssen, Tjalf
    Akguen, Katja
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 339 - 340
  • [48] HUMORAL IMMUNE RESPONSE TO SARS-COV-2 VACCINE IN RITUXIMAB-TREATED PATIENTS
    Flores-Fernandez, E.
    Vazquez-Gomez, I.
    Valera-Ribera, C.
    Andujar-Brazal, P.
    Valls-Pascual, E.
    Nogueira Coito, J. M.
    Martinez-Ferrer, A.
    Ybanez-Garcia, D.
    Alegre-Sancho, J. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 974 - 975
  • [49] Six-month humoral response to mRNA SARS-CoV-2 vaccine in People with Multiple Sclerosis under Ocrelizumab and Fingolimod
    Borgo, R.
    Bisecco, A.
    Capuano, R.
    Conte, M.
    Donnarumma, G.
    Altieri, M.
    Grimaldi, E.
    Franci, G.
    Chianese, A.
    Galdiero, M.
    Coppola, N.
    Tedeschi, G.
    Gallo, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 815 - 815
  • [50] Antibody response to SARS-CoV-2 vaccination following typical and three-dose dosing schedules in multiple sclerosis patients treated with disease modifying therapies
    Wallach, Asya I.
    Schiebel, Matthew
    Picone, Mary Ann
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 63
12345